THC and THC-COOH detection from DBS by LC-MS/MS. Cannabis use assessment from a finger-prick sample.
This method detects THC and its primary metabolite THC-COOH in dried blood spots, enabling assessment of recent cannabis use or exposure.
Clinical indications include:
THC (Δ9-tetrahydrocannabinol) and THC-COOH (11-nor-9-carboxy-THC, primary inactive metabolite).
Both analytes are measured by isotope-dilution LC-MS/MS from DBS, providing specific and sensitive detection of cannabis use without cross-reactivity with other cannabinoids or interfering substances.
Thc is an important biomarker for detection of recent cannabis use. Masdiag measures thc using validated analytical methods to provide clinically actionable results.
Thc testing is valuable for Detection of recent cannabis use, Assessment of passive cannabis exposure. Understanding thc levels helps inform personalized health optimization and clinical decision-making.
Thc collection is simple and convenient: prick your finger at home to collect a dried blood spot (DBS). This allows remote sampling without venepuncture.
This test is recommended for individuals interested in detection of recent cannabis use. Masdiag thc testing helps guide personalized supplementation and health optimization strategies based on objective biomarker data.
Thc results provide insight into your metabolic status and detection of recent cannabis use. Combined with clinical context, Masdiag results inform evidence-based interventions for personalized health optimization.
Whether you need testing services, method transfer, or white-label kit development — we'd love to hear from you.